CCT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.154800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.262000E-01
Normal-vs-Stage2
7.226800E-01
Normal-vs-Stage3
4.329400E-01
Normal-vs-Stage4
1.471760E-01
Stage1-vs-Stage2
4.038200E-01
Stage1-vs-Stage3
1.545390E-01
Stage1-vs-Stage4
2.854800E-01
Stage2-vs-Stage3
3.146200E-01
Stage2-vs-Stage4
6.889800E-01
Stage3-vs-Stage4
1.171410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.802000E-01
Normal-vs-AfricanAmerican
7.172800E-01
Normal-vs-Asian
5.419200E-01
Caucasian-vs-AfricanAmerican
8.871000E-01
Caucasian-vs-Asian
7.077800E-01
AfricanAmerican-vs-Asian
6.781400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.517000E-01
Normal-vs-Female
8.167400E-01
Male-vs-Female
1.329010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.218000E-01
Normal-vs-Age(41-60Yrs)
1.414170E-02
Normal-vs-Age(61-80Yrs)
9.220000E-01
Normal-vs-Age(81-100Yrs)
7.165600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.866400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.871800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.403600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.676200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.369780E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.203400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.359200E-01
Normal-vs-Daily Drinker
8.526400E-01
Normal-vs-Weekly Drinker
9.405000E-01
Normal-vs-Occasional Drinker
4.466100E-02
Normal-vs-Social Drinker
8.629600E-01
Non Drinker-vs-Daily Drinker
8.012200E-01
Non Drinker-vs-Weekly Drinker
4.887400E-01
Non Drinker-vs-Occasional Drinker
2.578000E-02
Non Drinker-vs-Social Drinker
3.469000E-01
Daily Drinker-vs-Weekly Drinker
6.626600E-01
Daily Drinker-vs-Occasional Drinker
3.394200E-02
Daily Drinker-vs-Social Drinker
5.415600E-01
Weekly Drinker-vs-Occasional Drinker
7.108300E-02
Weekly Drinker-vs-Social Drinker
9.733600E-01
Occasional Drinker-vs-Social Drinker
5.536000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.140400E-01
Normal-vs-Grade 2
9.117400E-01
Normal-vs-Grade 3
9.514400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.018400E-01
Grade 1-vs-Grade 3
5.763400E-01
Grade 1-vs-Grade 4
9.140400E-01
Grade 2-vs-Grade 3
7.904600E-01
Grade 2-vs-Grade 4
9.117400E-01
Grade 3-vs-Grade 4
9.514400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.211200E-01
Normal-vs-NonDiabetic
7.675200E-01
Diabetic-vs-NonDiabetic
7.517000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.111400E-01
Normal-vs-NoPancreatitis
7.344800E-01
Pancreatitis-vs-NoPancreatitis
1.164820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.030200E-01
Normal-vs-N1
7.012400E-01
N0-vs-N1
4.423400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.588400E-02
Normal-vs-TP53-NonMutant
5.801000E-01
TP53-Mutant-vs-TP53-NonMutant
4.515700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
